IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q2 2023 Holdings

Filed 2023-08-14 | 7 holdings | $34.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Savara Inc(SVRA)COM805111101$16.0M4,980,80446.2%
Xeris Biopharma Holdings Inc(XERS)COM98422E103$14.8M5,641,92042.7%
Rezolute Inc(RZLT)COM NEW76200L309$2.6M1,318,9677.5%
Molecular Templates IncCOM608550109$985.4K2,052,9912.8%
Compass Therapeutics Inc(CMPX)COM20454B104$138.2K43,4660.4%
Allakos Inc(ALLKGUSD)COM01671P100$77.3K17,7330.2%
Elevation Oncology IncCOM28623U101$33.0K21,7250.1%